Show simple item record

dc.creatorBaily, Mary Annen
dc.creatorMurray, Thomas H.en
dc.date.accessioned2011-07-12T18:21:33Zen
dc.date.available2011-07-12T18:21:33Zen
dc.date.created2008-05en
dc.date.issued2008-05en
dc.identifier0093-0334en
dc.identifier.bibliographicCitationHastings Center Report 2008 May-June; 38(3): 23-31en
dc.identifier.urihttp://hdl.handle.net/10822/512884en
dc.description.abstractWhen deciding what disorders to screen newborns for, we should be guided by evidence of real effectiveness, take opportunity cost into account, distribute costs and benefits fairly, and respect human rights. Current newborn screening policy does not meet these requirements.en
dc.formatArticleen
dc.languageengen
dc.source316270en
dc.subjectCosts And Benefitsen
dc.subjectEthicsen
dc.subjectHuman Rightsen
dc.subjectNewbornsen
dc.subjectRightsen
dc.subject.classificationAllocation of Health Care Resourcesen
dc.subject.classificationDrugs and Drug Industryen
dc.subject.classificationGenetic Screening / Genetic Testingen
dc.subject.classificationEconomics of Health Careen
dc.subject.classificationHealth Care for Newborns and Minorsen
dc.titleEthics, evidence, and cost in newborn screening.en
dc.provenanceDigital citation created by the Bioethics Research Library, Georgetown University, for the National Information Resource on Ethics and Human Genetics, a project funded by the United States National Human Genome Research Instituteen
dc.provenanceDigital citation migrated from OpenText Livelink Discovery Server database named GenETHX to DSpace collection GenETHX hosted by Georgetown Universityen


This item appears in the following Collection(s)

Show simple item record


Georgetown University Seal
©2009—2022 Bioethics Research Library
Box 571212 Washington DC 20057-1212
202.687.3885